209 related articles for article (PubMed ID: 31900843)
1. Effects of montelukast sodium plus budesonide on lung function, inflammatory factors, and immune levels in elderly patients with asthma.
Zhang Y; Li B
Ir J Med Sci; 2020 Aug; 189(3):985-990. PubMed ID: 31900843
[TBL] [Abstract][Full Text] [Related]
2. Montelukast and Budesonide for Childhood Cough Variant Asthma.
Sun W; Liu HY
J Coll Physicians Surg Pak; 2019 Apr; 29(4):345-348. PubMed ID: 30925958
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.
Zhang Y; Wang H
Pharmazie; 2019 Nov; 74(11):694-697. PubMed ID: 31739840
[TBL] [Abstract][Full Text] [Related]
4. [Micro-invasive embedding combined with montelukast sodium for children cough variant asthma:a randomized controlled trial].
Wang X; Liu B; Lu B; Zhang Y; Wang L; Li H; Han X; Ding D
Zhongguo Zhen Jiu; 2017 Mar; 37(3):259-264. PubMed ID: 29231431
[TBL] [Abstract][Full Text] [Related]
5. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children.
Karaman O; Arli O; Uzuner N; Islekel H; Babayigit A; Olmez D; Kose S; Tezcan D
Allergy Asthma Proc; 2007; 28(2):204-9. PubMed ID: 17479606
[TBL] [Abstract][Full Text] [Related]
7. Montelukast versus budesonide as a first line preventive therapy in mild persistent asthma in 2 to 18 y.
Shah MB; Gohil J; Khapekar S; Dave J
Indian J Pediatr; 2014 Jul; 81(7):655-9. PubMed ID: 24553973
[TBL] [Abstract][Full Text] [Related]
8. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
10. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Szefler SJ; Carlsson LG; Uryniak T; Baker JW
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
[TBL] [Abstract][Full Text] [Related]
11. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
12. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
Ceylan E; Gencer M; Aksoy S
Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
14. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study.
Rajanandh MG; Nageswari AD; Ilango K
Clin Ther; 2014 Apr; 36(4):526-33. PubMed ID: 24650447
[TBL] [Abstract][Full Text] [Related]
17. Effect of budesonide combined with montelukast sodium on pulmonary function parameters and immunoglobulin levels in children with bronchial asthma.
Chu F; Liang L; Chen F
Allergol Immunopathol (Madr); 2023; 51(4):151-157. PubMed ID: 37422792
[TBL] [Abstract][Full Text] [Related]
18. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
Hoshino M; Akitsu K; Ohtawa J
J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
[No Abstract] [Full Text] [Related]
19. Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum.
Wei H; Li W; Jiang Z; Xi X; Qi G
Exp Ther Med; 2019 Jul; 18(1):411-417. PubMed ID: 31258680
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: A meta-analysis.
Yang S; He X; Zhang R
Pediatr Pulmonol; 2024 Jun; 59(6):1541-1551. PubMed ID: 38501316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]